FDA Inspection
Antonio E. Blanco, M.D.Antonio E. Blanco, M.D. – FDA Inspection, Jan 30, 2023
Record Details
This FDA Inspection record concerns Antonio E. Blanco, M.D., with an inspection on January 30, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d164703d-fd78-4dc5-b3da-e9f2b0f2adb8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1196096
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Antonio E. Blanco, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2025 | Not classified | Florida District Office | |
| December 5, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Antonio E. Blanco, M.D.
- FDA Inspection 1259612 - 2025-01-24
- FDA Inspection 1114128 - 2019-12-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.